You Searched For "cannabis control board" and got 20 results
Sort By:
The ultimate guide to cannabis legalization in New York: The key dates to know, and which stocks could benefit the most.
New York's recreational cannabis industry has the potential to become a $7 billion market. Here's w…
Yeji Jesse Lee
A timeline of when New Yorkers can smoke marijuana, grow it, and sell it legally
Smoking marijuana and possessing up to 3 oz. of cannabis is now legal for New Yorkers over the age …
Jake Lahut,Yeji Jesse Lee
New York Legislature legalizes recreational marijuana for adults
Set to take effect in 2022, New York's legal cannabis bill will allow for home growing, dispensary …
Jake Lahut,Yeji Jesse Lee
San Francisco bans tobacco but not cannabis smoking in apartments to counter secondhand smoke effects
The city's Board of Supervisors passed an amended ordinance after the original proposal only exempt…
Naina Bhardwaj
CULTIVATED: Wealth managers open up to cannabis stocks, top 25 cannabis startups, and more.
Their earnings were two bright spots among a backdrop of slumping cannabis stocks, many of which ha…
Jeremy Berke
CULTIVATED: 7 cannabis stocks to bet on for a Biden win — Fyllo's $26 million pitch deck — Canopy CEO says he's bullish
Welcome to Cultivated, where we're bringing you an inside look at the deals, trends, and personalit…
Jeremy Berke
A CDC study found people who smoked cannabis had a slightly higher risk of fungal infections than those who didn't
People who use cannabis and are immunocompromised could be at risk for deadly complications like pn…
Julia Naftulin
CULTIVATED: DCM Ventures makes a bet on cannabis drinks, Wall Street's leading cannabis analyst on her top 3 US picks, and more
In other news, I sat down with Bradley Tusk, the CEO of Tusk Ventures and author of "The Fixer" in …
Jeremy Berke
Curaleaf just snapped up Grassroots Cannabis for $875 million, making it the biggest cannabis retailer. We talked to Curaleaf's CEO about what's next.
Eight Capital, a boutique Canadian investment bank, acted as a financial advisor on the transaction…
Jeremy Berke
CULTIVATED: Layoffs hit Canndescent, KPMG rakes in millions from cannabis companies, and more.
The complexities around the cannabis space - namely, rapidly changing laws, volatile stock prices, …
Jeremy Berke
CULTIVATED: 2019 was the year the cannabis bubble burst, where top VCs are placing their bets, and more.
Featured Digital Health Articles: - Telehealth Industry: Benefits, Services & Examples - Valu…
Jeremy Berke
A top cannabis private equity fund manager reveals how he picks companies to invest in
That's a key component of what makes the cannabis industry a challenging opportunity for investors …
Jeremy Berke
CULTIVATED: Recruiters share their 3 best tips for landing a job in cannabis, Headset CEO walks us through his pitch deck, and vape-related illnesses
A bit of bad news, however: I was really excited for some big, quality hurricane-fueled surf out at…
Jeremy Berke
One of the world's largest tobacco giants is teaming up with Snoop Dogg's VC firm to invest in medical cannabis research
The move is a sign of a larger shift within Imperial, which is behind popular cigarette brands like…
Jeremy Berke
The world's largest cannabis company has a new CEO, and Wall Street is betting it's a sign that Canopy Growth's investors aren't willing to wait for results to improve
"Broadly we believe the announcement will be welcomed for a number of reasons," wrote Jefferies ana…
Jeremy Berke
The man who built Canopy Growth into the world's biggest cannabis grower before being ousted told us why he picked pet-food CBD and psychedelics for his next ventures
CannTrust let the Canadian cannabis sector "take punch after punch because of their bad behavior," …
Jeremy Berke
A top cannabis CEO talks about what's next following a $300 million merger, and says he's playing 'Risk' while his competitors are playing 'Monopoloy'
Cannex trades on the Canadian Securities Exchange, a secondary exchange in Canada that has become t…
Jeremy Berke
Here's What A Post-War Approach To Drug Control Could Look Like
Latin American leaders are tiring of this. Trying to stop the flow of narcotics is akin to the lege…
The Economist
The drugmaker that hopes to legalize MDMA is cutting 75% of its staff after the FDA rejected the drug
Lykos will cut 75% of its staff, or about 100 employees, and the remaining team will focus on worki…
Shubhangi Goel
Here's where Kamala Harris stands on the issues, from the economy to healthcare
VP Kamala Harris became the leading contender for the Democratic nomination Sunday. Here's where sh…